| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/13/2009 | CN101427995A Anticancer sustained-release agent |
| 05/13/2009 | CN101427994A Gemcitabine-containing anti-cancer medicine sustained-release injection |
| 05/13/2009 | CN101427993A Prostaglandin microemulsion gel rubber preparation and method of producing the same |
| 05/13/2009 | CN101427992A Clopidogrel hydrobromate preparation and method of producing the same |
| 05/13/2009 | CN101427988A Moisture paper tissue containing hamamelidaceae plant extract liposome |
| 05/13/2009 | CN101427983A Female washing and protecting condensation with sterilizing effect and method of producing the same |
| 05/13/2009 | CN100487032C Inclusion daidzein/cyclodextrin composition, and its preparing method |
| 05/13/2009 | CN100487020C Perfluoropolyether derivative, solution composition containing the same and treatment basis material thereof |
| 05/13/2009 | CN100486988C Process for preparing 20(R)-ginsenoside Rh2 |
| 05/13/2009 | CN100486987C Antivira and antitumor deoxyoligonucleotide containing CpG single strand |
| 05/13/2009 | CN100486985C 9a-azalides with anti-inflammatory activity |
| 05/13/2009 | CN100486973C Novel benzodioxoles |
| 05/13/2009 | CN100486971C Compound 2,3,4,6,8-pentamethoxyl-dibenzofuran and its use |
| 05/13/2009 | CN100486969C Cis-2,4,5-triphenyl-imidazoline and its application in tumor treatment |
| 05/13/2009 | CN100486967C 5HT2C receptor modulators |
| 05/13/2009 | CN100486957C Process for producing amine derivatives |
| 05/13/2009 | CN100486645C Medicine composition containing cyclodextrin included taxol and its preparation process |
| 05/13/2009 | CN100486637C Composition of external remedy for treating hemorrhoids, and preparation method |
| 05/13/2009 | CN100486633C External use Chinese medicine for treating burn and scold and its preparing method |
| 05/13/2009 | CN100486616C Aerosol and its preparation method |
| 05/13/2009 | CN100486596C Chinese medicine preparation with organism immunity increasing function |
| 05/13/2009 | CN100486591C Traditional Chinese and western style oral composite nutrient formulation for treating type 2 diabetes |
| 05/13/2009 | CN100486589C Slow release antibiotics preparation of bioactive substance |
| 05/13/2009 | CN100486588C Single-chain deoxidized oligonucleotide containing CPG of resisting infuenza virus |
| 05/13/2009 | CN100486587C Clarithromycin liposome microsphere injection and its preparation method |
| 05/13/2009 | CN100486586C Imature bitter orange total flavone and its preparing method for its preparation and quality control method |
| 05/13/2009 | CN100486585C Antitumor ginsenoside Rh2 injection and its preparation process |
| 05/13/2009 | CN100486584C Application of amygdalin in preparation of amygdalin preparation for promoting the blood circulation of heart, brain, pancreas and wound |
| 05/13/2009 | CN100486583C Diabetin for injection and its preparation process |
| 05/13/2009 | CN100486582C Liniment for treating flat wart |
| 05/13/2009 | CN100486581C Progesterone membrane agent and its preparing method |
| 05/13/2009 | CN100486580C 6-aryl-7-halo-imidazo[1,2-A]pyrimidines as anticancer agents |
| 05/13/2009 | CN100486579C Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin b1 |
| 05/13/2009 | CN100486578C Medicine composition and its application in preparation of medicine for treating or preventing cardiovascular and cerebrovascular diseases |
| 05/13/2009 | CN100486577C Nimodipine lipid nano particle compositions, and its preparation method |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/13/2009 | CN100486575C Pharmaceutical composition for treating bacterial infection of milched cow, preparation process and use thereof |
| 05/13/2009 | CN100486574C Remedies and/or preventives for nervous system disorders |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/13/2009 | CN100486572C Medicament form of tatin class |
| 05/13/2009 | CN100486571C Methods of treating benzodiazepine site (BZD-s) associated syndromes using 2' hydroxyflavonoids |
| 05/13/2009 | CN100486570C Use of luciferin and derivatives in preparing medicine for treating live animal secretory diarrhea and inhibiting cyst growth |
| 05/13/2009 | CN100486569C Poly olefinic taxadol self assembled precusor liposome and its preparation method |
| 05/13/2009 | CN100486568C Loxoprofen sodium sustained release preparation |
| 05/13/2009 | CN100486567C Curcumin emulsion and its preparation process |
| 05/13/2009 | CN100486566C New type quick oral disintegration tablet of Subing and preparation method |
| 05/13/2009 | CN100486560C Slow released compound anticancer injection containing blood vessel inhibitor |
| 05/12/2009 | US7531695 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 05/12/2009 | US7531693 Lipids for transfection of nucleic acids |
| 05/12/2009 | US7531692 wherein the carboxylic group is linked to a residue allowing the passage of the blood-brain barrier; residue is represented by the amide of an alpha-amino acid and preferably is glycinamide; beta amyloid peptide (A beta 42) antagonist; Alzheimer's disease |
| 05/12/2009 | US7531676 Bipolar; cationic head linked to a hydrophobic backbone and a hydrophilic tail; capable of self assembly to form stable complexes in aqueous solutions; use for the delivery of bioactive substances such as nucleic acids to cells in vitro and especially in vivo |
| 05/12/2009 | US7531662 Cinchona-alkaloid-based catalysts, and asymmetric alcoholysis of cyclic anhydrides using them |
| 05/12/2009 | US7531651 e.g. 4-({[({[(2S)-4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}amino)carbonyl]amino}methyl)benzamide benzenesulfonate dihydrate; chemokine (C-C motif) receptor antagonist; antiinflammatory agent; asthma, rhinitis |
| 05/12/2009 | US7531650 Cephalosporin salts in crystalline form |
| 05/12/2009 | US7531649 Methods that allow the identification of aptamers to receptor tyrosine kinases such as HER3 as well as specific aptamers that recognize these molecules |
| 05/12/2009 | US7531646 β-D-ribosidase activity indicators with a chromogenic substrate |
| 05/12/2009 | US7531635 Monoclonal antibodies or functional fragment; immunoassay kit; female fertility diagnosis; Premature ovarian failure |
| 05/12/2009 | US7531604 Phospholipid derivative containing a polyoxyalkylene group comprising two or more kinds of alkylene oxides, as well as a surfactant, solubilizer, dispersing agent; for cosmetics and lipid membrane structures; drug delivery of antitumor agents |
| 05/12/2009 | US7531577 3-Fluoro-N-(5-ureidomethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-benzenesulfonamide; serotonin receptors 5-HT6 and 5-HT2A ligand; neurodegenerative disorders; antidepressant, anxiolytic agent; Parkinson's disease, Huntington's disease, manic depression, psychoses, epilepsy, obesity, drug abuse |
| 05/12/2009 | US7531575 Upregulating or downregulating microglial cells which synthesize nitric oxide; 2-[[3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl]amino]benzoic acid; Parkinson's, Alzheimer's Diseases, AIDS |
| 05/12/2009 | US7531573 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease |
| 05/12/2009 | US7531572 Acyloxyalkyl carbamate prodrugs of α-amino acids, methods of synthesis and use |
| 05/12/2009 | US7531571 4-benzyl-2-phenylchroman skeleton with hydroxyl substitutions compounds; estrogen beta -receptors (ER beta ) modulator; hormone replacement therapy; osteoporosis, postmenopause; side effect reduction |
| 05/12/2009 | US7531570 Interleukin-1 beta converting enzyme inhibitor: 3-(1-((4-amino-3-chlorobenzoylamino)tert-butylacetyl)-2-pyrrolidinylcarbonylamino)-3-formylpropionic acid or 4-(1-((4-amino-3-chlorobenzoylamino)tert-butylacetyl)-2-pyrrolidinylcarbonylamino)-5-ethoxy-2-tetrahydrofuranone; autoinflammatory diseases |
| 05/12/2009 | US7531569 Process for preparing (3-oxo-2,3-dihydro-1H-isoindol-1-yl) acetylguanidine derivatives |
| 05/12/2009 | US7531568 e.g. [5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yloxy]-acetic acid; peroxisome proliferator activated receptor agonist; anticoagulant, antidiabetic agent; obesity, hyperlipidemia, hypertriglyceridemia, Syndrome X, insulin resistance, diabetic neuropathy, atherosclerosis, eczema, psoriasis |
| 05/12/2009 | US7531567 effector ambroxole with ACE inhibitors; treatment of a disturbance of the thiol-disulfide status in kidney replacement therapy |
| 05/12/2009 | US7531566 Anti-inflammatory medicaments |
| 05/12/2009 | US7531565 Imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS) |
| 05/12/2009 | US7531564 Substituted benzoxazoles as estrogenic agents |
| 05/12/2009 | US7531563 e.g. 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-thiazole-4(S)-carboxylic acid; ferrochelatase; thalassemia, anemia; diagnosing and treating pathological conditions associated with excess of trivalent metals (such as Fe, Al and Cr) |
| 05/12/2009 | US7531562 Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy |
| 05/12/2009 | US7531561 GSK-3 inhibitors |
| 05/12/2009 | US7531560 Anti-cytokine heterocyclic compounds |
| 05/12/2009 | US7531559 Fungicidal 1,2,3 triazole derivatives |
| 05/12/2009 | US7531558 Carboxamide derivatives |
| 05/12/2009 | US7531557 oral bioavailablility, oral administration; inhibition of orexigenic effects; side effects reduction; alcoholism; 6-(2-Fluoro-4-{[2-(tetrahydro-pyran-4-yl)-ethylamino]-methyl}-phenoxy)-nicotinamide |
| 05/12/2009 | US7531556 Compositions useful as inhibitors of rock and other protein kinases |
| 05/12/2009 | US7531555 Central nervous system disorders; schizophrenia; anxiolytic agents; Alzheimer's disease; Huntington's disease |
| 05/12/2009 | US7531554 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| 05/12/2009 | US7531553 Heterocyclic compounds and methods of use |
| 05/12/2009 | US7531552 antiviral for HIV and AIDS; N-(1-Benzoyl-pyrrolidin-3-ylmethyl)-2-(4-fluoro-1H-indol-3-yl)-2-oxo-acetamide; N-(1-Benzoyl-pyrrolidin-3-ylmethyl)-2-oxo-2-(1H-pyrrolo[2,3-b]pyridin-3-yl)-acetamide |
| 05/12/2009 | US7531551 Polymorphs of cabergoline |
| 05/12/2009 | US7531550 Pseudobase benzo[c]phenanthridines with improved efficacy, stability, and safety |
| 05/12/2009 | US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 05/12/2009 | US7531548 to inhibit the replication of mutant strains, in particular strains which are resistant to NNRTI drugs (Non Nucleoside Reverse Transcriptase Inhibitor drugs); to treat HIV infections |
| 05/12/2009 | US7531547 Diaminopyrimidines as P2X3 and P2X2/3 modulators |
| 05/12/2009 | US7531546 inhibitors of cysteine proteases; neuropathic pain, inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis, tumors, obesity, coronary disease, atherosclerosis; 6-(2-Acetyl-2,8-diaza-spiro[4.5]dec-8-ylmethyl)-7-(2-cyclohexyl-ethyl)-7H-pyrrolo[2,3d]pyrimidine-2-carbonitrile |
| 05/12/2009 | US7531545 2-amino-3,4-dihydro-pyrido[3,4-d]pyrimidine derivatives useful as inhibitors of β-secretase (BACE) |
| 05/12/2009 | US7531544 Xanthine phosphodiesterase V inhibitors |
| 05/12/2009 | US7531543 Phenylpiperazine cycloalkanol derivatives and methods of their use |
| 05/12/2009 | US7531542 Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| 05/12/2009 | US7531541 Metabotropic glutamate receptor antagonists; phenylethynylpyrimidines and phenylethynylpyrazines; treating anxiety, epilepsy, schizophrenia, other psychotic disorder, Parkinson's disease, or addictive disorder |
| 05/12/2009 | US7531540 phosphodiesterase type 4 inhibitors; to treat respiratory disorders, skin disorders like psoriasis and atopic eczema; low toxicity, high bioavailability, no significant side effects; 2-{4-[(4aS,8aR)-4-(3,4-dimethoxyphenyl)-1-oxo-4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-acetamide |
| 05/12/2009 | US7531539 Inhibit tyrosine kinase activity of Trk receptors; antiproliferative agents, anticancer agents; cancer, psoriasis or rheumatoid arthritis; N4-pyrazol-5-yl-pyrrolo[2,1-f] [1,2,4]triazine-2,4-diamines |
| 05/12/2009 | US7531538 α- and β-Amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 05/12/2009 | US7531537 Benzofuran derivative |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531535 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 05/12/2009 | US7531534 e.g. N-{3-[(S)-5-tert-Butyl-1-(3-chloro-4-fluoro-benzyl)-4-hydroxy-2-oxo-2,5-dihydro-1H-pyrrol-3-yl]-2-chloro-1,1-dioxo-1,4-dihydro-1 lambda 6-benzo[1,4]thiazin-7-yl}-methanesulfonamide; viricide; hepatitis C virus polymerase inhibitor |